ClinicalTrials.gg
RecruitingNCT07337278Updated Jan 13, 2026

Posturography Rehabilitation and Pelvic Floor Training on Urinary Incontinence in Women

An interventional study of Pelvic Floor Muscle Training and Posturography Rehabilitation in Urinary Incontinence, sponsored by Mohammed V University in Rabat. Recruiting at 1 site in Morocco. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by Mohammed V University in Rabat · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate whether lumbopelvic postural rehabilitation combined with pelvic floor muscle training (PFMT) is more effective than PFMT alone in women with urinary incontinence. The main questions it aims to answer are:

  • Does the addition of lumbopelvic postural rehabilitation improve the severity of urinary incontinence as measured by the ICIQ-UI-SF questionnaire?
  • Does it improve urinary symptom profile, pelvic floor muscle strength, patient-reported overall improvement, and quality of life compared to PFMT alone?

Participants will be randomly assigned to one of two groups:

  • Experimental group (Group A): PFMT (3 sessions/week) plus lumbopelvic postural rehabilitation (2 sessions/week) for 12 weeks.
  • Control group (Group B): PFMT alone (3 sessions/week) for 12 weeks. Participants will perform pelvic floor exercises in supine and seated positions, with supervised sessions at the hospital and home exercises. Postural rehabilitation includes stability and mobility exercises for the lumbopelvic region using Posturography. Outcomes will be assessed at baseline, at 6 weeks, and at 12 weeks.
02

Conditions studied

  • Urinary Incontinence

Browse trials for

Keywords

  • Urinary incontinence, Pelvic floor, Lumbopelvic static, Posturography
03

In context

Urinary Incontinence

983 studies on the registry are indexed under Urinary Incontinence; 180 are open to participants now.

This study's planned enrollment of 78 is above the median of 66 across 739 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

Mohammed V University in Rabat is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged between 18 and 65 years
  • Presence of clinical signs of urinary incontinence (stress urinary incontinence and/or urge urinary incontinence and/or mixed urinary incontinence) diagnosed according to the International Continence Society (ICS) terminology
  • USP (urinary symptom profile) scores for stress urinary incontinence and/or overactive bladder ≥ 1
  • Normal neuro-perineal examination
  • Written provided prior to participation in the study

Exclusion criteria

Exclusion Criteria:

  • Known detrusor overactivity or reduced bladder compliance of neurological origin
  • Associated voiding dysfunction, defined as a Urinary Symptom Profile (USP) dysuria subscale score ≥ 1
  • Known organic or morphological pathology of the lower urinary tract
  • Pelvic organ prolapse grade II or higher according to the Pelvic Organ Prolapse Quantification system (POP-Q)
  • Current urinary tract infection or vaginal infection
  • Cognitive or visual impairments that may interfere with understanding or performing the exercise program
  • Pregnant women or women within 10 months postpartum
  • Anticholinergic medication use or hormone replacement therapy within the last 6 months
  • Recent pelvic or abdominal surgery within the last 6 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Combined Pelvic Floor Muscle Training and Posturography Rehabilitation

    Participants receive pelvic floor muscle training combined with lumbopelvic rehabilitation using posturography for a total duration of 12 weeks.

    Behavioral: Pelvic Floor Muscle Training · Behavioral: Posturography Rehabilitation

  • Active comparator
    Pelvic Floor Muscle Training Alone

    Participants receive pelvic floor muscle training alone for a total duration of 12 weeks.

    Behavioral: Pelvic Floor Muscle Training

Interventions

  • BehavioralPelvic Floor Muscle Training

    Pelvic floor training consists of voluntary contractions of the pelvic floor muscles, using short, rapid contractions combined with slow, sustained contractions, aimed at improving strength and endurance. Training is performed in supine and seated positions, with one supervised session per week at the hospital and three home sessions per week, over a total duration of 12 weeks.

  • BehavioralPosturography Rehabilitation

    Postural rehabilitation consists of seated exercises focusing on stability and mobility of the lumbopelvic region, using posturography. Sessions last 30 minutes, conducted twice weekly, over a total duration of 12 weeks.

06

What researchers measure

Primary outcomes

  1. International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF)

    The primary outcome is the severity of urinary incontinence measured by the ICIQ-UI-SF. This validated questionnaire assesses frequency, quantity, and impact of leaks on quality of life. The overall score is obtained by adding up the 3 questions, ranging from 0 to 21, with a higher score indicating more severe symptoms.

    Time frame: 6 weeks and 12 weeks from start of intervention

Secondary outcomes

  1. Patient Global Impression of Improvement (PGI-I)

    PGI-I is a patient-reported questionnaire assessing overall improvement in urinary symptoms compared to baseline. Scores range from "considerably improved" to "considerably worsened".

    Time frame: 6 weeks and 12 weeks from start of intervention

  2. Urinary Symptom Profile (USP) scores

    questionnaire enabling qualitative and quantitative analysis of urinary symptoms of stress urinary incontinence, overactive bladder, and dysuria. We used the subscores for stress urinary incontinence and overactive bladder.

    Time frame: 6 weeks and 12 weeks from start of intervention

  3. Pelvic Floor Muscle Strength (Modified Oxford Scale)

    The modified Oxford scale assesses pelvic floor muscle strength through vaginal palpation and visual observation during maximum voluntary contraction. The classification ranges from 0 (no contraction) to 5 (strong contraction)

    Time frame: 6 weeks and 12 weeks from start of intervention

  4. Incontinence Impact Questionnaire - Short Form (IIQ-7)

    IIQ-7 measures the impact of urinary incontinence on daily activities, social relationships, mobility, and emotional health. Each item is scored from 0 (not at all) to 3 (greatly), with higher total scores indicating greater impact.

    Time frame: 6 weeks and 12 weeks from start of intervention

07

Study locations

1 of 1 sites recruiting
  • Al Ayachi Hospital, CHU Ibn Sina
    Rabat, Rabat-Salé-Kénitra 10000, Morocco
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07337278
Lead sponsor
Mohammed V University in Rabat
Responsible party
Khaoula Mestour (Resident in Physical and Rehabilitation Medicine, Mohammed V University in Rabat) — Principal investigator
First posted
Jan 13, 2026
Start date
Nov 20, 2025
Primary completion
Feb 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Jan 13, 2026

Study contacts

Khaoula Mestour
Contact
khaoulamestour00@gmail.com
+212 6 17 70 82 62

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion